Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement mediators in ischemia-reperfusion injury.

Thiruma V Arumugam1, Tim Magnus, Trent M Woodruff

  • 1Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, 5600 Nathan Shock Drive, Baltimore, MD 21224, USA.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|July 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperacute Interleukin-1β Production and Neutrophil Extracellular Trap Formation in the Cerebral Circulation of Stroke Patients with Large Vessel Occlusion.

Annals of neurology·2026
Same author

Timed microglia depletion promotes functional network reorganization and motor recovery after stroke.

Brain communications·2026
Same author

Neuroglial P2Y<sub>1</sub> receptor signalling differentially contributes to inflammatory neurodegeneration.

Journal of neuroinflammation·2026
Same author

Neurotransmitter-Informed Connectome Approach to Language Impairment After Stroke.

Stroke·2026
Same author

Transient restructuring of the active oral resistome during probiotic <i>Streptococcus salivarius</i> K12 colonization in a 3D polymicrobial biofilm model.

Journal of oral microbiology·2026
Same author

Genetically engineered bacterial magnetosomes as optimized tracers for magnetic particle imaging.

Acta biomaterialia·2026

Ischemia-reperfusion injury triggers inflammation via complement activation. Blocking this system with inhibitors like sCR1 or C5a antibodies can reduce tissue damage, offering potential new therapies for this common clinical event.

Area of Science:

  • Immunology
  • Pathophysiology

Background:

  • Ischemia-reperfusion (I/R) injury involves tissue damage from blood flow restoration after deprivation, triggering inflammation.
  • The complement system, a key part of innate immunity, exacerbates I/R injury by promoting inflammation and tissue damage.
  • Increased complement activity is a significant factor in the pathology of I/R injury, affecting blood vessels and leukocytes.

Purpose of the Study:

  • To critically review existing literature on the role of complement in ischemia-reperfusion (I/R) injury.
  • To explore therapeutic strategies targeting the complement system for managing I/R injuries.

Main Methods:

  • Comprehensive literature search of Medline and the World Wide Web.
  • Classification of reviewed studies into four categories: complement pathways, complement and inflammation, complement in I/R injury, and therapeutic approaches.

Related Experiment Videos

Main Results:

  • Complement activation is a potent inducer of inflammation in I/R injury, generating mediators like anaphylatoxins (C3a, C5a) and the membrane attack complex (C5b-9).
  • Inhibitors targeting various complement cascade levels, including sCR1, C1-INH, C5a antibodies, C5a receptor antagonists, and sCD59, have demonstrated efficacy in reducing I/R injury in different organs.

Conclusions:

  • Complement activation significantly contributes to the pathophysiology of I/R injury, leading to substantial tissue damage.
  • Targeting the complement system with specific inhibitors presents a promising therapeutic avenue for I/R injuries, addressing a current lack of effective treatments.